Table 3 Patient demographics and baseline characteristics of the four phenotypes of PCOS

Total number of patients (n)

47

6

14

7

Age (years)

34.3 (25–49)

38.9 (36–40)

32.7 (27–43)

34.2 (31–38)

Body Weight (kg)

75.5 (46.7–117.0)

66.9 (54.4–81.6)

60.2 (51.0–104.0)

60.5 (47.0–79.4)

BMI (kg/m²)

28.8 (18.7–40.0)

24.0 (19.2–29.0)

24.3 (19.2–37.4)

22.3 (17.8–29.1)

Menstrual cycle Duration (days)

33.5 (16–60)

27 (23–30)

28.5 (26–32)

28.5 (26–33)

AMH level (pmol/l)

55.5 (2.2–131.7)

7.9 (2.7–11.4)

30.4 (5.2–82.1)

26.1 (14.4–33.8)

AFC- for both ovaries (n)

38.7 (1–40)

13.5 (3–19)

25 (10–40)

24 (15–30)

Average time interval between hormone analysis (AMH) and start of treatment with follitropin delta (months)

6.7

5.8

6

7.4

Number of patients prescribed treatments for infertility prior to ovarian stimulation (lifestyle modifications/metformin, etc) (n)

21

3

2

3

Number of patients on agonist protocols (n)

0

0

2

0

Number of patients on antagonist protocols (n)

47

6

12

7

Number of first IVF/ICSI cycles (n)

31

6

10

4

Number of subsequent IVF/ICSI cycles (n)

16

0

4

3